ARKG vs EMB
ARK Genomic Revolution ETF vs iShares JP Morgan USD Emerging Markets Bond ETF
- • EMB has the lower expense ratio at 0.39% vs 0.75% for ARKG.
- • EMB pays a higher dividend yield (5.06%).
Side-by-side metrics
| Metric | ARKG | EMB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.75% | 0.39% |
Dividend yield Trailing 12-month yield. | 0.00% | 5.06% |
AUM Assets under management — bigger funds are typically more liquid. | $1.24B | $14.51B |
YTD return | 7.21% | 1.76% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 2.35 | 1.06 |
P/E ratio | — | — |
Last price | $30.38 | $95.90 |
Inception | — | — |
Issuer | ARK | iShares |
ARKG top holdings
| TEM | Tempus AI Inc Class A common stock | 9.45% |
| TWST | Twist Bioscience Corp | 9.02% |
| CRSP | CRISPR Therapeutics AG | 8.94% |
| TXG | 10x Genomics Inc Ordinary Shares - Class A | 5.78% |
| BEAM | Beam Therapeutics Inc | 5.44% |
| ABSI | Absci Corp | 4.79% |
| NTRA | Natera Inc | 4.08% |
| ILMN | Illumina Inc | 4.04% |
| NTLA | Intellia Therapeutics Inc | 3.83% |
| PSNL | Personalis Inc | 3.59% |
EMB top holdings
| XTSLA | BlackRock Cash Funds Treasury SL Agency | 0.90% |
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology. Managed by ARK, the fund carries $1.2B in assets under management, an expense ratio of 0.75%. Its largest holding is Tempus AI Inc Class A common stock (TEM), which represents 9.4% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About EMB
EMB (iShares JP Morgan USD Emerging Markets Bond ETF) is USD-denominated emerging market government bonds. Managed by iShares, the fund carries $14.5B in assets under management, an expense ratio of 0.39%, a dividend yield of 5.06%. Its largest holding is BlackRock Cash Funds Treasury SL Agency (XTSLA), which represents 0.9% of the portfolio.